Skip to content Skip to footer

Our Services

Unique Technologies

Consectetur adipiscing elit, sed do eiusmod tempo.

Endless Possibilities

Consectetur adipiscing elit, sed do eiusmod tempo.

Reliable Experts

Consectetur adipiscing elit, sed do eiusmod tempo.

Excellent Support

Consectetur adipiscing elit, sed do eiusmod tempo.
What we do

Explore the power of AI tools, developed with ingenuity, brilliance, quality and pride

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

People
0+
Adipiscing elit, do eiusm.
World Offices
0
Adipiscing elit, do eiusm.

AI Image Generator FAQs

Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim.

Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim.

Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
My Skill
Web Designer 50%
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
John Doe
Designer
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Subtitle

First action

Some description text for this item
Subtitle

Second action

Some description text for this item
Subtitle

Third action

Some description text for this item
0
First item
0
Second item
0
Third item

Our Services

Unique Technologies

Consectetur adipiscing elit, sed do eiusmod tempo.

Endless Possibilities

Consectetur adipiscing elit, sed do eiusmod tempo.

Reliable Experts

Consectetur adipiscing elit, sed do eiusmod tempo.

Excellent Support

Consectetur adipiscing elit, sed do eiusmod tempo.
What we do

Explore the power of AI tools, developed with ingenuity, brilliance, quality and pride

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

People
0+
Adipiscing elit, do eiusm.
World Offices
0
Adipiscing elit, do eiusm.

AI Image Generator FAQs

Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim.

Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim.

Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
My Skill
Web Designer 50%
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
John Doe
Designer
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Subtitle

First action

Some description text for this item
Subtitle

Second action

Some description text for this item
Subtitle

Third action

Some description text for this item
0
First item
0
Second item
0
Third item
cancerx_white_transparent-sm

No information contained on this website should be construed as a forward-looking statement.

CanceRx Foundation, Inc., is an IRS approved tax-exempt public charitable foundation under Sec. 501(c)(3) of the U.S. Internal Revenue Code.

CanceRx® is a registered trademark.

To learn more, please call or email:

CanceRx Foundation, Inc.

4830 W Kennedy Blvd, Suite 600
Tampa, FL 33609-2584

Phone: (813) 776-0000

Email: donations@cancerx-foundation.org

CanceRx © 2025. All Rights Reserved.
The Bottom Line

Why Haven't We Cured Cancer?

Each day brings more news about promising discoveries about cancer. But most of these discoveries will never result in a cure. Why?

Our society has been great at funding early scientific discoveries. But we have failed to follow through to deliver the final treatments for patients. We can get the job done by turning more promising discoveries into lifesaving medicines.

Watch Dr. Lo's Ted Talk to find out why more cures don't get to patients.

If we want to cure cancer, we must  pay for it.”

Dr. Andrew Lo, PhD, MIT, Laboratory for Financial Engineering, Sloan School of Management

Here is how we can do better financing clinical development:

The CanceRx financing model was developed by Dr. Andrew Lo and the Nobel Laureate faculty at Massachusetts Institute of Technology’s Laboratory for Financial Engineering. This approach uses bonds to fund long-term, uninterrupted support for clinical development and human trials.

Our Team

Proven in funding cancer research.
Read More

For Scientists

Clinical support and licensing royalties.
Read More

For Clinicians

A new breed of supportive CRO.
Read More
why it matters

Many Promising Innovations Can Be Saved

There are tens of thousands of new cures flowing from academia, cancer centers, and biotechs. But they are just sitting on the shelf. Getting more of them through clinical development can bring more lifesaving treatments to patients.

A new drug sitting on the shelf could help you, or someone you know. We need to pick up where discovery leaves off and put more new drugs into human clinical testing.”

Tracy Christianson, CanceRx Clinical Research Consultant

We often hear exciting news about new discoveries, only to learn that they need to be proven in clinical trials. Here are the three phases of creating new medicines:

Basic and Preclinical Research – Government, drug companies and philanthropy fund lab studies to uncover possible new cures. Basic science in cancer has moved rapidly.   

Phase I-II Clinical Development – To be approved as a medicine, discoveries first must be tested in people. Many new cures never get this far – due to shortfalls of private venture capital.

Phase III-IV Trials – Drug companies often prefer to buy new drugs after Phase II. They put the new treatments into large scale clinical trials to finish proving they are viable.

Screenshot-2024-12-13PM
WHAT IS OUR GAME PLAN?

Accelerating Clinical Studies at Scale

CanceRx will leverage advanced tools, fundamentally changed financial modeling and acohesive clinical trial network to advance the most promising technologies in cancer development.

01. How we will choose candidates for clinical investigation
02. How we will use real-time data to select which candidates to advance

Subscribe for the exclusive updates!


    The Bottom Line

    Why Haven't We Cured Cancer?

    Each day brings more news about promising discoveries about cancer. But most of these discoveries will never result in a cure. Why?

    Our society has been great at funding early scientific discoveries. But we have failed to follow through to deliver the final treatments for patients. We can get the job done by turning more promising discoveries into lifesaving medicines.

    Watch Dr. Lo's Ted Talk to find out why more cures don't get to patients.

    If we want to cure cancer, we must  pay for it.”

    Dr. Andrew Lo, PhD, MIT, Laboratory for Financial Engineering, Sloan School of Management

    Here is how we can do better financing clinical development:

    The CanceRx financing model was developed by Dr. Andrew Lo and the Nobel Laureate faculty at Massachusetts Institute of Technology’s Laboratory for Financial Engineering. This approach uses bonds to fund long-term, uninterrupted support for clinical development and human trials.

    Our Team

    Proven in funding cancer research.
    Read More

    For Scientists

    Clinical support and licensing royalties.
    Read More

    For Clinicians

    A new breed of supportive CRO.
    Read More
    why it matters

    Many Promising Innovations Can Be Saved

    There are tens of thousands of new cures flowing from academia, cancer centers, and biotechs. But they are just sitting on the shelf. Getting more of them through clinical development can bring more lifesaving treatments to patients.

    A new drug sitting on the shelf could help you, or someone you know. We need to pick up where discovery leaves off and put more new drugs into human clinical testing.”

    Tracy Christianson, CanceRx Clinical Research Consultant

    We often hear exciting news about new discoveries, only to learn that they need to be proven in clinical trials. Here are the three phases of creating new medicines:

    Basic and Preclinical Research – Government, drug companies and philanthropy fund lab studies to uncover possible new cures. Basic science in cancer has moved rapidly.   

    Phase I-II Clinical Development – To be approved as a medicine, discoveries first must be tested in people. Many new cures never get this far – due to shortfalls of private venture capital.

    Phase III-IV Trials – Drug companies often prefer to buy new drugs after Phase II. They put the new treatments into large scale clinical trials to finish proving they are viable.

    Screenshot-2024-12-13PM
    WHAT IS OUR GAME PLAN?

    Accelerating Clinical Studies at Scale

    CanceRx will leverage advanced tools, fundamentally changed financial modeling and acohesive clinical trial network to advance the most promising technologies in cancer development.

    01. How we will choose candidates for clinical investigation
    02. How we will use real-time data to select which candidates to advance

    Subscribe for the exclusive updates!


      Go to Top